The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Attention Deficit Hyperactivity Disorder-Global Market Insights and Sales Trends 2024
Synopsis
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
The global Attention Deficit Hyperactivity Disorder market size is expected to reach US$ 15440 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Attention Deficit Hyperactivity Disorder in various end use industries. The expanding demands from the Pediatric, Adolescent and Adults,, are propelling Attention Deficit Hyperactivity Disorder market. Stimulants Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-stimulants Drugs segment is estimated at % CAGR for the next seven-year period.
There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.
ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2022.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Attention Deficit Hyperactivity Disorder market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Attention Deficit Hyperactivity Disorder market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Attention Deficit Hyperactivity Disorder sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Attention Deficit Hyperactivity Disorder covered in this report include Eli Lilly, Novartis, Takeda, Pfizer, GlaxoSmithKline, Mallinckrodt, Hisamitsu, Johnson & Johnson and Purdue Parma, etc.
The global Attention Deficit Hyperactivity Disorder market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Novartis
Takeda
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Johnson & Johnson
Purdue Parma
Global Attention Deficit Hyperactivity Disorder market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Attention Deficit Hyperactivity Disorder market, Segment by Type:
Stimulants Drugs
Non-stimulants Drugs
Global Attention Deficit Hyperactivity Disorder market, by Application
Pediatric
Adolescent
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Attention Deficit Hyperactivity Disorder companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
The global Attention Deficit Hyperactivity Disorder market size is expected to reach US$ 15440 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Attention Deficit Hyperactivity Disorder in various end use industries. The expanding demands from the Pediatric, Adolescent and Adults,, are propelling Attention Deficit Hyperactivity Disorder market. Stimulants Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-stimulants Drugs segment is estimated at % CAGR for the next seven-year period.
There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.
ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2022.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Attention Deficit Hyperactivity Disorder market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Attention Deficit Hyperactivity Disorder market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Attention Deficit Hyperactivity Disorder sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Attention Deficit Hyperactivity Disorder covered in this report include Eli Lilly, Novartis, Takeda, Pfizer, GlaxoSmithKline, Mallinckrodt, Hisamitsu, Johnson & Johnson and Purdue Parma, etc.
The global Attention Deficit Hyperactivity Disorder market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Novartis
Takeda
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Johnson & Johnson
Purdue Parma
Global Attention Deficit Hyperactivity Disorder market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Attention Deficit Hyperactivity Disorder market, Segment by Type:
Stimulants Drugs
Non-stimulants Drugs
Global Attention Deficit Hyperactivity Disorder market, by Application
Pediatric
Adolescent
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Attention Deficit Hyperactivity Disorder companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Attention Deficit Hyperactivity Disorder
1.1 Attention Deficit Hyperactivity Disorder Market Overview
1.1.1 Attention Deficit Hyperactivity Disorder Product Scope
1.1.2 Attention Deficit Hyperactivity Disorder Market Status and Outlook
1.2 Global Attention Deficit Hyperactivity Disorder Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Attention Deficit Hyperactivity Disorder Market Size by Region (2018-2029)
1.4 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Region (2018-2023)
1.5 Global Attention Deficit Hyperactivity Disorder Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Attention Deficit Hyperactivity Disorder Market Size (2018-2029)
1.6.1 North America Attention Deficit Hyperactivity Disorder Market Size (2018-2029)
1.6.2 Europe Attention Deficit Hyperactivity Disorder Market Size (2018-2029)
1.6.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size (2018-2029)
1.6.4 Latin America Attention Deficit Hyperactivity Disorder Market Size (2018-2029)
1.6.5 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size (2018-2029)
2 Attention Deficit Hyperactivity Disorder Market by Type
2.1 Introduction
2.1.1 Stimulants Drugs
2.1.2 Non-stimulants Drugs
2.2 Global Attention Deficit Hyperactivity Disorder Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Type (2018-2023)
2.2.2 Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Attention Deficit Hyperactivity Disorder Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Attention Deficit Hyperactivity Disorder Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Attention Deficit Hyperactivity Disorder Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Attention Deficit Hyperactivity Disorder Revenue Breakdown by Type (2018-2029)
3 Attention Deficit Hyperactivity Disorder Market Overview by Application
3.1 Introduction
3.1.1 Pediatric
3.1.2 Adolescent
3.1.3 Adults
3.2 Global Attention Deficit Hyperactivity Disorder Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Application (2018-2023)
3.2.2 Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Attention Deficit Hyperactivity Disorder Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Attention Deficit Hyperactivity Disorder Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Attention Deficit Hyperactivity Disorder Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Attention Deficit Hyperactivity Disorder Revenue Breakdown by Application (2018-2029)
4 Attention Deficit Hyperactivity Disorder Competition Analysis by Players
4.1 Global Attention Deficit Hyperactivity Disorder Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder as of 2022)
4.3 Date of Key Players Enter into Attention Deficit Hyperactivity Disorder Market
4.4 Global Top Players Attention Deficit Hyperactivity Disorder Headquarters and Area Served
4.5 Key Players Attention Deficit Hyperactivity Disorder Product Solution and Service
4.6 Competitive Status
4.6.1 Attention Deficit Hyperactivity Disorder Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.2.4 Novartis Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Takeda
5.3.1 Takeda Profile
5.3.2 Takeda Main Business
5.3.3 Takeda Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.3.4 Takeda Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.4.4 Pfizer Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.5.4 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Mallinckrodt
5.6.1 Mallinckrodt Profile
5.6.2 Mallinckrodt Main Business
5.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.6.4 Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.6.5 Mallinckrodt Recent Developments
5.7 Hisamitsu
5.7.1 Hisamitsu Profile
5.7.2 Hisamitsu Main Business
5.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.7.4 Hisamitsu Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.7.5 Hisamitsu Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.8.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Purdue Parma
5.9.1 Purdue Parma Profile
5.9.2 Purdue Parma Main Business
5.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Products, Services and Solutions
5.9.4 Purdue Parma Attention Deficit Hyperactivity Disorder Revenue (US$ Million) & (2018-2023)
5.9.5 Purdue Parma Recent Developments
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Attention Deficit Hyperactivity Disorder Market Dynamics
11.1 Attention Deficit Hyperactivity Disorder Industry Trends
11.2 Attention Deficit Hyperactivity Disorder Market Drivers
11.3 Attention Deficit Hyperactivity Disorder Market Challenges
11.4 Attention Deficit Hyperactivity Disorder Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
